Detection of hepatitis B virus DNA by polymerase chain reaction in vaccinated and non-vaccinated Senegalese children
An hepatitis B immunization programme was initiated in Senegal in 1978, and infants included in this controlled study have been followed for a period of 2–12 years after immunization. During this period HBV infections have been observed both in vaccinated and non-vaccinated infants. The polymerase chain reaction was used to search for HBV DNA sequences in the sera of 153 children with evidence of serum markers of past or present HBV replication. Amplified HBV DNA sequences were detected in 93% of the HBsAg positive individuals, in 58% of those only positive for antiHBc antibodies and in 7.8% of antiHBs and antiHBc positive infants. The results confirm the high efficiency and long-lasting effectiveness of HB vaccine.
KeywordsHBsAg Carrier HBsAg Positive Individual Thiers Versus Senegalese Child
Unable to display preview. Download preview PDF.
- 1.Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology 2: 21–26Google Scholar
- 3.Bréchot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trépo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P, Berthelot P (1985) Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 321: 270–276CrossRefGoogle Scholar
- 6.Coursaget P, Yvonnet B, Chotard J, Sarr M, Vincelot P, N’Doye R, Diop-Mar I, Chiron JP (1986) Seven years study of hepatitis B vaccine efficacy in infants from an endemic area ( Senegal ). Lancet ii: 1143–1145Google Scholar
- 8.Coursaget P, Leboulleux D, Soumare M, Le Cann P, Yvonnet B, Chiron JP, Coll- Secka M, Diop-Mar I (1993) Twelve-year follow-up study of hepatitis B vaccination of Senegalese infants. J Hepatol (in press)Google Scholar
- 9.Diamantis ID, Mc Gandy C, Pult I, Bühler H, Schmid M, Gudat F, Bianchi L (1992) Polymerase chain reaction detects hepatitis B virus DNA in paraffin-embedded liver tissue from patients sero and histo-negative for active hepatitis B. Virchows Archiv A Pathol Anat Histopathol 420: 11–15CrossRefGoogle Scholar
- 10.Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle H (1993) Break-through infections and identification of a viral mutant in Gambian children immunised with hepatitis B vaccine (submitted)Google Scholar
- 14.Lai ME, Farci P, Figus A, Balestrieri A, Arnone M, Vyas GN (1989) Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood 73: 17–18 /30Google Scholar
- 18.Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J, Denis F, Diop-Mar I (1981b) Efficacity of hepatitis B vaccine in prevention of early HBsAg carrier state in children controlled trial in an endemic area ( Senegal ). Lancet i: 289–292Google Scholar
- 19.Paterlini P, Gerken G, Nakajima E, Terre S, D’Errico A, Grigioni W, Franco D, Nalpas B, Wands J, Kew M, Pisi E, Tiollais P, Brechot C (1990) Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 323: 80–85PubMedCrossRefGoogle Scholar
- 22.Thiers V, Nakajima E, Kremsdorf K, Mack K, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, Brechot C (1988) Transmission of hepatitis B from hepatitis B seronegative subjects. Lancet ii: 1273–1276Google Scholar